Literature DB >> 34108782

Eosinophilic Granulomatosis with Polyangiitis Presenting as Unilateral Acute Anterior Ischaemic Optic Neuropathy.

Anthony Fong1,2, Shahzada Ahmed3, Satheesh Ramalingam4, Rachel M Brown5, Lorraine Harper6, Susan P Mollan1.   

Abstract

Eosinophilic granulomatosis with polyangiitis (eGPA) is a rare vasculitis of small-medium sized vessels that can cause both anterior and posterior ischaemic optic neuropathies. Herein, the authors present a rare case of eGPA presenting initially as an acute unilateral anterior ischaemic optic neuropathy from short posterior ciliary artery vasculitis. The diagnosis presented a challenge as clinical and histopathological evidence suggested allergic rhinosinusitis, and no invasive fungal sinusitis was found. The high serum eosinophilia, asthma, optic neuropathy and paranasal sinus abnormalities fulfilled the criteria for a diagnosis of eGPA. Furthermore serum was positive for myeloperoxidase antibodies. Subsequently the case was successfully treated with oral glucocorticoids and intravenous rituximab.
© 2020 Taylor & Francis Group, LLC.

Entities:  

Keywords:  Eosinophilic granulomatosis with polyangiitis; fungal sinusitis; loss of vision; optic neuropathy; vasculitis

Year:  2020        PMID: 34108782      PMCID: PMC8158048          DOI: 10.1080/01658107.2020.1761402

Source DB:  PubMed          Journal:  Neuroophthalmology        ISSN: 0165-8107


  20 in total

1.  Allergic granulomatosis, allergic angiitis, and periarteritis nodosa.

Authors:  J CHURG; L STRAUSS
Journal:  Am J Pathol       Date:  1951 Mar-Apr       Impact factor: 4.307

Review 2.  Eosinophilic Granulomatosis with Polyangiitis: Clinical Pathology Conference and Review.

Authors:  Eveline Y Wu; Michelle L Hernandez; J Charles Jennette; Ronald J Falk
Journal:  J Allergy Clin Immunol Pract       Date:  2018 Sep - Oct

Review 3.  Imaging in Sinonasal Inflammatory Disease.

Authors:  Varsha M Joshi; Rima Sansi
Journal:  Neuroimaging Clin N Am       Date:  2015-11       Impact factor: 2.264

4.  Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on antimyeloperoxidase antibodies.

Authors:  H K Choi; S Liu; P A Merkel; G A Colditz; J L Niles
Journal:  J Rheumatol       Date:  2001-07       Impact factor: 4.666

Review 5.  Fungi in chronic hyperplastic eosinophilic sinusitis: reasonable doubt.

Authors:  Larry Borish; Lanny Rosenwasser; John W Steinke
Journal:  Clin Rev Allergy Immunol       Date:  2006-06       Impact factor: 8.667

Review 6.  Eosinophilic chronic rhinosinusitis.

Authors:  Shigeharu Fujieda; Yoshimasa Imoto; Yukinori Kato; Takahiro Ninomiya; Takahiro Tokunaga; Toshiki Tsutsumiuchi; Kanano Yoshida; Masanori Kidoguchi; Tetsuji Takabayashi
Journal:  Allergol Int       Date:  2019-08-09       Impact factor: 5.836

7.  Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies.

Authors:  Richard Watts; Suzanne Lane; Thomas Hanslik; Thomas Hauser; Bernhard Hellmich; Wenche Koldingsnes; Alfred Mahr; Mårten Segelmark; Jan W Cohen-Tervaert; David Scott
Journal:  Ann Rheum Dis       Date:  2006-08-10       Impact factor: 19.103

8.  Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis.

Authors:  Michael E Wechsler; Praveen Akuthota; David Jayne; Paneez Khoury; Amy Klion; Carol A Langford; Peter A Merkel; Frank Moosig; Ulrich Specks; Maria C Cid; Raashid Luqmani; Judith Brown; Stephen Mallett; Richard Philipson; Steve W Yancey; Jonathan Steinfeld; Peter F Weller; Gerald J Gleich
Journal:  N Engl J Med       Date:  2017-05-18       Impact factor: 91.245

Review 9.  Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome.

Authors:  J G Lanham; K B Elkon; C D Pusey; G R Hughes
Journal:  Medicine (Baltimore)       Date:  1984-03       Impact factor: 1.889

Review 10.  Eosinophilic Granulomatosis with Polyangiitis: Experiences in Korean Patients.

Authors:  Chan Bum Choi; Yong Beom Park; Sang Won Lee
Journal:  Yonsei Med J       Date:  2019-08       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.